StockNow
Log in
U.S. Markets

Boston Scientific (BSX) has invested USD 1.5bln for an approximately 34% equity stake in MiRus

News detail

The agreement includes an exclusive option to acquire MiRus's SIEGEL Balloon Expandable TAVR system through additional aggregate cash payments of USD 3bln, contingent on clinical and regulatory milestones.  The investment is expected to be immaterial to adj. earnings per share in 2026.

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYU.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)

Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement